Go Pro

XOMA (XOMAP) Competitors

XOMA logo
$24.97 0.00 (0.00%)
Closing price 07/2/2026 03:56 PM Eastern
Extended Trading
$24.95 -0.02 (-0.08%)
As of 07/2/2026 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

XOMAP vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy XOMA stock or one of its competitors? MarketBeat compares XOMA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with XOMA include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does XOMA compare to Ainos?

XOMA (NASDAQ:XOMAP) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Ainos N/A N/A N/A

In the previous week, XOMA's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
XOMA Neutral
Ainos Neutral

Summary

XOMA beats Ainos on 1 of the 1 factors compared between the two stocks.

How does XOMA compare to Alvotech?

XOMA (NASDAQ:XOMAP) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Alvotech had 2 more articles in the media than XOMA. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for XOMA. Alvotech's average media sentiment score of 0.50 beat XOMA's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
XOMA Neutral
Alvotech Positive

Summary

Alvotech beats XOMA on 3 of the 3 factors compared between the two stocks.

How does XOMA compare to Aravive?

XOMA (NASDAQ:XOMAP) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, XOMA's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
XOMA Neutral
Aravive Neutral

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Aravive beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to Atlantic Coastal Acquisition Corp. II?

XOMA (NASDAQ:XOMAP) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, XOMA's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
XOMA Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

XOMA beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does XOMA compare to Biofrontera?

XOMA (NASDAQ:XOMAP) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, XOMA's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
XOMA Neutral
Biofrontera Neutral

Summary

Biofrontera beats XOMA on 1 of the 1 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XOMAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XOMAP vs. The Competition

MetricXOMABiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$431.50M$7.16B$12.48B
Dividend Yield9.29%3.88%2.66%6.52%
P/E RatioN/A3.0928.0224.70
Price / SalesN/A6,669.11540.3799.49
Price / CashN/A13.1349.2657.09
Price / BookN/A88.6710.966.46
Net IncomeN/A-$96.07M$3.57B$337.01M
7 Day Performance-1.98%0.17%2.12%1.69%
1 Month Performance-1.89%2.10%5.25%3.81%
1 Year Performance-1.85%68.02%33.29%23.90%

XOMA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XOMAP
XOMA
N/A$24.97
flat
N/A-1.8%$0.00$7.65MN/A10
AIMDW
Ainos
N/A$0.12
-4.4%
N/A+14.2%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.17
flat
N/A-90.2%$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:XOMAP) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners